SCHEMBL2182293

SCHEMBL2182293

CC(=O)OC(=O)CC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
GAA P10253 2/20 0.36
MIF P14174 1/20 0.34
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
RAB9A P51151 1/20 0.31
HMGCR P04035 1/20 0.31
CHRM1 P11229 1/20 0.31
TBXA2R P21731 1/20 0.31
ADRA1A P35348 1/20 0.31
MGAM O43451 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL385886 0.86 ALDH1A1 (0.41) ALDH1A1TSHRTDP1MIFLMNA
SCHEMBL182236 0.79 ALDH1A1 (0.42) ALDH1A1TDP1GAAMIFLMNA
SCHEMBL1406215 0.78 ALDH1A1 (0.39) ALDH1A1TSHRHSD17B10TDP1GAA
SCHEMBL28874728 0.78 MIF (0.32) MIFLMNA
SCHEMBL28362979 0.78 MIF (0.32) MIFLMNA
SCHEMBL1634881 0.77 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10TDP1GAA
SCHEMBL7500157 0.77 MIF (0.37) MIFLMNASMN1; SMN2NPC1TP53
SCHEMBL7905388 0.77 MIF (0.33) ALDH1A1MIFLMNASMN1; SMN2NPC1
SCHEMBL4644724 0.77 CYP2D6 (0.33) TSHRMIFLMNASMN1; SMN2NPC1
SCHEMBL801 0.77 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025083736-A1 NOVEL PROCESS FOR THE PREPARATION OF PIRTOBRUTINIB AND ITS INTERMEDIATES THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2025-04-24 WO claimed
CN-109651224-A A kind of fluorescence protein crosslinking agent and preparation method thereof 苏州昊帆生物股份有限公司 2019-04-19 CN claimed
WO-2015087351-A2 PROCESS FOR THE PREPARATION OF (1S,3S,7S,10R,11S,12S,16R)-7,11-DIHYDROXY-8,8,10,12,16-PENTAMETHYL-3-[(1E)-1-METHYL-2-(2-METHYL-4-THIAZOLYL)ETHENYL]-17-OXA-4-AZABICYCLO[14.1.0]HEPTADECANE-5,9-DIONE AND INTERMEDIATES THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2015-06-18 WO claimed
CN-1693334-A Process of preparing polyester resin for reflectorized film LU YAJIAN (CN) 2005-11-09 CN claimed
US-12232415-B2 Molecular materials based on phenoxyazine core for heterojunction organic solar cells SUMITOMO CHEMICAL CO., LTD. (JP) 2025-02-18 US disclosed
US-12137612-B2 Organic photodetector SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2024-11-05 US disclosed
WO-2024079127-A1 COMPOSITION FOR ORGANIC PHOTOVOLTAIC DEVICES SUMITOMO CHEMICAL CO., LTD (JP) 2024-04-18 WO disclosed
US-20230094427-A1 COMPOSITION SUMITOMO CHEMICAL CO., LTD. (JP) 2023-03-30 US disclosed
US-20220407015-A1 MOLECULAR MATERIALS BASED ON PHENOXYAZINE CORE FOR HETEROJUNCTION ORGANIC SOLAR CELLS SUMITOMO CHEMICAL CO., LTD. (JP) 2022-12-22 US disclosed
US-20220315605-A1 IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2022-10-06 US disclosed
EP-4048669-A1 MOLECULAR MATERIALS BASED ON PHENOXYAZINE CORE FOR HETEROJUNCTION ORGANIC SOLAR CELLS Sumitomo Chemical Co., Ltd (JP) 2022-08-31 EP disclosed
US-20220251052-A1 IMPROVED PROCESS FOR THE PREPARATION OF 2-(3,5-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2022-08-11 US disclosed
WO-1993017065-A2 PROCESS FOR PRODUCING A CROSSLINKED POLYMER USING A β-DICARBONYL COMPOUND BASF CORPORATION (US) 1993-09-02 WO disclosed
WO-1992014694-A1 THERMOSETTING COATING COMPOSITIONS EASTMAN KODAK COMPANY (US) 1992-09-03 WO disclosed
EP-0494481-A1 Coating composition of acrylic polymers containing reactive groups and an epoxy organosilane E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-07-15 EP disclosed
EP-0483420-A1 Coating composition of an acrylic polymer containing glycidyl groups and acetoacetoxy groups and an amino ester acrylic polymer E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-05-06 EP disclosed
US-5064719-A Exterior finishes for automobiles, trucks E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-11-12 US disclosed
US-4988759-A Room temperature curable polymer solution of solvent and an acrylic polymer as binders E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-29 US disclosed
US-4987177-A AUTOMOBILE AND TRUCK FINISHES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-22 US disclosed
US-4609734-A Process for the production of 2-hydroxypyridines from 2-pyridine carboxylic acid-N-oxides LONZA LTD. (CH) 1986-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220407015-A1 MOLECULAR MATERIALS BASED ON PHENOXYAZINE CORE FOR HETEROJUNCTION ORGANIC SOLAR CELLS ESRRG, OR10J3, KCNJ5 ALDH1A1 1615/4885TSHR 1877/4885HSD17B10 3780/4885
US-20220251052-A1 IMPROVED PROCESS FOR THE PREPARATION OF 2-(3,5-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF TTR, CYP2D6, CYP2C9 ALDH1A1 185/4885TSHR 3431/4885HSD17B10 735/4885
US-20220315605-A1 IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF UGT1A7, CYP3A7, UGT1A6 ALDH1A1 162/4885TSHR 885/4885HSD17B10 1026/4885
US-12232415-B2 Molecular materials based on phenoxyazine core for heterojunction organic solar cells ESRRG, OR10J3, KCNJ5 ALDH1A1 1615/4885TSHR 1877/4885HSD17B10 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.